Background: This study aimed to investigate the presence of sexual dysfunction (SD) in patients with Chronic Venous Disease (CVD) and if CVD treatments may have an impact on SD evolution in these patients. Methods: Inclusion criteria were patients of both sexes and genders, with minimum age of 18, with first diagnosis of CVD. Exclusion criteria were presence of known sexual dysfunction of organic origin, arterial system diseases, malignancies and endocrine system diseases. Included patients were administered the ASEX (Arizona Sexual Experience) questionnaire that was administered at the moment of study inclusion (T0), and for patients that resulted affected from sexual dysfunction, were administered also, after CVD treatments at 6 months (T1) and after 12 months (T2). Results: A total of 649 patients with CVD were recruited. After the administration of the ASEX questionnaire, 122 patients (18.8 %) resulted affected from SD. Female sex, C3–C6 clinical stages, and the presence of Coronary Artery Disease (CAD), hypertension, and hyperlipidemia were more associated with the presence of SD. SD improved in all patients’ population, especially after CVD treatment at T2. Conclusions: CVD patients may experience SD, especially in female sex, in more advanced diseasestages. SD in CVD patients appears to improve after adequate CVD treatment.

Sex and the veins. A cross-sectional analysis on sexual dysfunction in patients with chronic venous disease / Costa, Davide; Ielapi, Nicola; Bracale, Umberto Marcello; Peluso, Antonio; Minici, Roberto; Andreucci, Michele; Serra, Raffaele. - In: HELIYON. - ISSN 2405-8440. - 10:9(2024), pp. 1-8. [10.1016/j.heliyon.2024.e30038]

Sex and the veins. A cross-sectional analysis on sexual dysfunction in patients with chronic venous disease

Ielapi, Nicola;
2024

Abstract

Background: This study aimed to investigate the presence of sexual dysfunction (SD) in patients with Chronic Venous Disease (CVD) and if CVD treatments may have an impact on SD evolution in these patients. Methods: Inclusion criteria were patients of both sexes and genders, with minimum age of 18, with first diagnosis of CVD. Exclusion criteria were presence of known sexual dysfunction of organic origin, arterial system diseases, malignancies and endocrine system diseases. Included patients were administered the ASEX (Arizona Sexual Experience) questionnaire that was administered at the moment of study inclusion (T0), and for patients that resulted affected from sexual dysfunction, were administered also, after CVD treatments at 6 months (T1) and after 12 months (T2). Results: A total of 649 patients with CVD were recruited. After the administration of the ASEX questionnaire, 122 patients (18.8 %) resulted affected from SD. Female sex, C3–C6 clinical stages, and the presence of Coronary Artery Disease (CAD), hypertension, and hyperlipidemia were more associated with the presence of SD. SD improved in all patients’ population, especially after CVD treatment at T2. Conclusions: CVD patients may experience SD, especially in female sex, in more advanced diseasestages. SD in CVD patients appears to improve after adequate CVD treatment.
2024
sexual dysfunction; chronic venous disease; quality of life; asex
01 Pubblicazione su rivista::01a Articolo in rivista
Sex and the veins. A cross-sectional analysis on sexual dysfunction in patients with chronic venous disease / Costa, Davide; Ielapi, Nicola; Bracale, Umberto Marcello; Peluso, Antonio; Minici, Roberto; Andreucci, Michele; Serra, Raffaele. - In: HELIYON. - ISSN 2405-8440. - 10:9(2024), pp. 1-8. [10.1016/j.heliyon.2024.e30038]
File allegati a questo prodotto
File Dimensione Formato  
Costa_Sex_2024.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 814.5 kB
Formato Adobe PDF
814.5 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1709212
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact